Ben Shahshahani, who previously worked at SiriusXM, will lead the health system’s AI strategy, including managing safety, ethics and data security concerns.
Cleveland Clinic appoints first chief AI officer Read More »
Back-to-back failures in psoriasis and Crohn’s disease have forced Ventyx Biosciences to abandon the development of its investigational oral TYK2 inhibitor VTX958.
Ventyx Ends Development of TYK2 Inhibitor After Phase II Flop in Crohn’s Disease Read More »
La instalación de fibra óptica FTTH es fundamental para garantizar una conexión a internet rápida y estable en los hogares. Este sistema se basa en llevar la fibra óptica directamente hasta la vivienda del usuario. A lo largo del artículo, se abordará …
Instalación fibra óptica FTTH: Guía completa y práctica Read More »
Adding to growing evidence of its benefits beyond glucose control and weight loss, Novo Nordisk’s Ozempic could also potentially help diabetics quit smoking, according to new research.
Novo Nordisk’s Ozempic Could Help Curb Cigarette Use in Diabetics: Study Read More »
AstraZeneca is seeking a fixed-duration approval for Calquence, which will allow patients with chronic lymphocytic leukemia to take breaks from the therapy and prevent excessive toxicities and drug resistance.
AstraZeneca’s Calquence Aces Phase III CLL Trial, Eyes Fixed-Duration Approval Read More »
The JAMA study comes as lawmakers debate whether to permanently expand telehealth flexibilities to providers this year.
Mental telehealth services have declined since end of pandemic emergency: study Read More »
BioNTech and Regeneron will face off against Merck and Moderna, which are advancing their investigational cancer vaccine mRNA-4157/V940 in combination with Keytruda, in advanced melanoma.
BioNTech, Regeneron’s mRNA Cancer Vaccine Combo Clears Phase II in Melanoma Read More »
The share of Americans who were either “cost insecure” or “cost desperate” when it comes to healthcare have both increased since 2022, a Gallup and West Health survey found.
Flagship Pioneering and its portfolio companies are in line to receive up to $720 million in milestones for each of the 10 programs that GSK could option, according to Monday’s announcement.
El cannabis es la droga ilegal más consumida en Europa. Se estima que alrededor del 8% de las personas adultas consumieron cannabis en 2022. El abuso generalizado de esta sustancia tiene consecuencias para la salud y se entiende como un problema social relevante. Un aliado fundamental para co …
Nuevo sistema, mejor y más rápido, para detectar en la saliva el consumo de cannabis Read More »
